HEPATITIS B VACCINE

본원은 변이 HBsAg 단백질 또는 B형 간염 바이러스 표면 항원의 항원성을 나타내는 그의단편을 기술한다. 이러한 변이 단백질 또는 이의 단편은 HBsAg 서열(vHBsAg)의 위치 145에서 글리신 이외의 다른 아미노산이 존재하는 변형된 a 결정소를 함유한다. 또한, 본원은 vHBsAg를 함유한 백신, 항-vHBsAg 항체의 시험관내 진단검색용키트, 및 항-vHBsAg 항체를 함유한 항체제제를 제공한다. A variant HBsAg protein of fragment thereof displaying the antigenicity...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: THOMAS, HOWARD CHRISTOPHER, CARMAN, WILLIAM FREDERICK
Format: Patent
Sprache:eng ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator THOMAS, HOWARD CHRISTOPHER
CARMAN, WILLIAM FREDERICK
description 본원은 변이 HBsAg 단백질 또는 B형 간염 바이러스 표면 항원의 항원성을 나타내는 그의단편을 기술한다. 이러한 변이 단백질 또는 이의 단편은 HBsAg 서열(vHBsAg)의 위치 145에서 글리신 이외의 다른 아미노산이 존재하는 변형된 a 결정소를 함유한다. 또한, 본원은 vHBsAg를 함유한 백신, 항-vHBsAg 항체의 시험관내 진단검색용키트, 및 항-vHBsAg 항체를 함유한 항체제제를 제공한다. A variant HBsAg protein of fragment thereof displaying the antigenicity of Hepatitis B virus surface antigen is disclosed, in which the variant protein or fragment thereof (vHBsAg) comprises a modified a determinant in which there is an amino acid other than glycine at position 145 of the HBsAg sequence. A vaccine comprising the vHBsAg is provided, as it is a kit for diagnostic in vitro detection of anti-vHBsAg antibodies and an antibody preparation comprising anti-vHBsAg antibodies.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR100208129BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR100208129BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR100208129BB13</originalsourceid><addsrcrecordid>eNrjZBD2cA1wDPEM8QxWcFIIc3R29vRz5WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BhgYGRgYWhkaWTk6GxsSpAgDBRh8S</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HEPATITIS B VACCINE</title><source>esp@cenet</source><creator>THOMAS, HOWARD CHRISTOPHER ; CARMAN, WILLIAM FREDERICK</creator><creatorcontrib>THOMAS, HOWARD CHRISTOPHER ; CARMAN, WILLIAM FREDERICK</creatorcontrib><description>본원은 변이 HBsAg 단백질 또는 B형 간염 바이러스 표면 항원의 항원성을 나타내는 그의단편을 기술한다. 이러한 변이 단백질 또는 이의 단편은 HBsAg 서열(vHBsAg)의 위치 145에서 글리신 이외의 다른 아미노산이 존재하는 변형된 a 결정소를 함유한다. 또한, 본원은 vHBsAg를 함유한 백신, 항-vHBsAg 항체의 시험관내 진단검색용키트, 및 항-vHBsAg 항체를 함유한 항체제제를 제공한다. A variant HBsAg protein of fragment thereof displaying the antigenicity of Hepatitis B virus surface antigen is disclosed, in which the variant protein or fragment thereof (vHBsAg) comprises a modified a determinant in which there is an amino acid other than glycine at position 145 of the HBsAg sequence. A vaccine comprising the vHBsAg is provided, as it is a kit for diagnostic in vitro detection of anti-vHBsAg antibodies and an antibody preparation comprising anti-vHBsAg antibodies.</description><edition>6</edition><language>eng ; kor</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19990715&amp;DB=EPODOC&amp;CC=KR&amp;NR=100208129B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19990715&amp;DB=EPODOC&amp;CC=KR&amp;NR=100208129B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>THOMAS, HOWARD CHRISTOPHER</creatorcontrib><creatorcontrib>CARMAN, WILLIAM FREDERICK</creatorcontrib><title>HEPATITIS B VACCINE</title><description>본원은 변이 HBsAg 단백질 또는 B형 간염 바이러스 표면 항원의 항원성을 나타내는 그의단편을 기술한다. 이러한 변이 단백질 또는 이의 단편은 HBsAg 서열(vHBsAg)의 위치 145에서 글리신 이외의 다른 아미노산이 존재하는 변형된 a 결정소를 함유한다. 또한, 본원은 vHBsAg를 함유한 백신, 항-vHBsAg 항체의 시험관내 진단검색용키트, 및 항-vHBsAg 항체를 함유한 항체제제를 제공한다. A variant HBsAg protein of fragment thereof displaying the antigenicity of Hepatitis B virus surface antigen is disclosed, in which the variant protein or fragment thereof (vHBsAg) comprises a modified a determinant in which there is an amino acid other than glycine at position 145 of the HBsAg sequence. A vaccine comprising the vHBsAg is provided, as it is a kit for diagnostic in vitro detection of anti-vHBsAg antibodies and an antibody preparation comprising anti-vHBsAg antibodies.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD2cA1wDPEM8QxWcFIIc3R29vRz5WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BhgYGRgYWhkaWTk6GxsSpAgDBRh8S</recordid><startdate>19990715</startdate><enddate>19990715</enddate><creator>THOMAS, HOWARD CHRISTOPHER</creator><creator>CARMAN, WILLIAM FREDERICK</creator><scope>EVB</scope></search><sort><creationdate>19990715</creationdate><title>HEPATITIS B VACCINE</title><author>THOMAS, HOWARD CHRISTOPHER ; CARMAN, WILLIAM FREDERICK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR100208129BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>1999</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>THOMAS, HOWARD CHRISTOPHER</creatorcontrib><creatorcontrib>CARMAN, WILLIAM FREDERICK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>THOMAS, HOWARD CHRISTOPHER</au><au>CARMAN, WILLIAM FREDERICK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HEPATITIS B VACCINE</title><date>1999-07-15</date><risdate>1999</risdate><abstract>본원은 변이 HBsAg 단백질 또는 B형 간염 바이러스 표면 항원의 항원성을 나타내는 그의단편을 기술한다. 이러한 변이 단백질 또는 이의 단편은 HBsAg 서열(vHBsAg)의 위치 145에서 글리신 이외의 다른 아미노산이 존재하는 변형된 a 결정소를 함유한다. 또한, 본원은 vHBsAg를 함유한 백신, 항-vHBsAg 항체의 시험관내 진단검색용키트, 및 항-vHBsAg 항체를 함유한 항체제제를 제공한다. A variant HBsAg protein of fragment thereof displaying the antigenicity of Hepatitis B virus surface antigen is disclosed, in which the variant protein or fragment thereof (vHBsAg) comprises a modified a determinant in which there is an amino acid other than glycine at position 145 of the HBsAg sequence. A vaccine comprising the vHBsAg is provided, as it is a kit for diagnostic in vitro detection of anti-vHBsAg antibodies and an antibody preparation comprising anti-vHBsAg antibodies.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; kor
recordid cdi_epo_espacenet_KR100208129BB1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
TESTING
VINEGAR
WINE
title HEPATITIS B VACCINE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T15%3A06%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=THOMAS,%20HOWARD%20CHRISTOPHER&rft.date=1999-07-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR100208129BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true